EI
TNGX icon

EAM Investors’s Tango Therapeutics TNGX Stock Holding History

EAM Investors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.19M Sell
134,014
-33,984
-20% -$840K 0.37% 125
2026
Q1 		$3.51M Buy
+167,998
New +$2.34M 0.41% 118
2023
Q4 		– Sell
-209,401
Closed -$2.36M – 376
2023
Q3 		$2.36M Buy
+209,401
New +$1.28M 0.46% 73

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

EAM Investors's TNGX Position: Q2 2026 in Review

EAM Investors reduced its Tango Therapeutics (TNGX) stake by 20% in Q2 2026, selling an estimated $840K and leaving 134,014 shares worth $4.19M. The position accounts for 0.37% of the portfolio, ranked #125.

EAM Investors first reported a position in TNGX in Q3 2023 and has held it in 3 quarters since. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • EAM Investors held 134,014 shares of Tango Therapeutics worth $4.19M as of Q2 2026.
  • EAM Investors sold 33,984 Tango Therapeutics shares in Q2 2026, an estimated $840K.
  • Tango Therapeutics made up 0.37% of EAM Investors's portfolio in Q2 2026, its #125 holding.
  • EAM Investors first reported a position in Tango Therapeutics in Q3 2023 and has held it in 3 quarters since.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.